Andrew Arno, Director at OncoCyte Corp (OCX), bought 50,000 shares at $2.16 ($108K) on 2019-09-17, disclosed to the SEC on 2019-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| XXII | BUY | 2024-01-08 | $17K | — | Filing → |
| OCX | BUY | 2022-12-28 | $88K | — | Filing → |
| SMSI | BUY | 2022-08-22 | $64K | — | Filing → |